États-Unis · Plateformes & données · MarketBeat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Target Cut by Needham & Company LLC

Publié par MarketBeat · États-Unis il y a 2 h

Needham & Company LLC lowered their price target on Rhythm Pharmaceuticals from $130.00 to $114.00 and set a "buy" rating on the stock in a report on Tuesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Target Cut by Needham & Company LLC

À lire aussi

USANA Health Sciences Non-GAAP EPS of -$0.11 misses by $0.22, revenue of $205.89M misses by $11.53M

Douglas Dynamics (PLOW) Q3 2026 Earnings Call Transcript

S&P 500 is looking over the edge of a technical cliff — what happens if it falls off?

Postal Realty earnings missed by $0.01, revenue topped estimates

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Target Cut by Needham & Company LLC

Partager

À lire aussi

USANA Health Sciences Non-GAAP EPS of -$0.11 misses by $0.22, revenue of $205.89M misses by $11.53M

Douglas Dynamics (PLOW) Q3 2026 Earnings Call Transcript

S&P 500 is looking over the edge of a technical cliff — what happens if it falls off?

Postal Realty earnings missed by $0.01, revenue topped estimates

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030